Form 8-K VERU INC. For: Jun 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
Veru partners with Novo Nordisk for obesity drug combination study
June 4, 2026 8:42 AM EDTVeru Inc. (NASDAQ: VERU) entered into a clinical supply agreement with Novo Nordisk A/S on June 2, 2026, for the company's Phase 2b PLATEAU clinical study.
The study will evaluate the combination of Veru's enobosarm, an oral selective androgen receptor modulator, with Novo Nordisk's... More
